Cognitive enhancement : a brief overview

Show simple item record

dc.contributor.author Outhoff, Kim
dc.date.accessioned 2016-05-30T05:35:56Z
dc.date.available 2016-05-30T05:35:56Z
dc.date.issued 2016
dc.description.abstract Cognitive enhancement involves the non-medical use of illicit and/or prescription drugs, such as agents prescribed for attention deficit/hyperactive disorder (ADHD) and narcolepsy, usually in order to stay awake and to counteract fatigue and loss of concentration, generally in the context of high workload and stress. Growing interest in taking prescription stimulant drugs for non-licensed purposes to improve academic, work and sporting performance has raised medical, ethical and regulatory issues. en_ZA
dc.description.department Pharmacology en_ZA
dc.description.librarian am2016 en_ZA
dc.description.uri http://www.safpj.co.za/index.php/safpj en_ZA
dc.description.uri http://www.tandfonline.com/oemd en_ZA
dc.identifier.citation Outhoff, K 2016, 'Cognitive enhancement : a brief overview', South African Family Practice, vol. 58, no. 1, pp. 16-18. en_ZA
dc.identifier.issn 2078-6190 (print)
dc.identifier.issn 2078-6204 (online)
dc.identifier.uri http://hdl.handle.net/2263/52779
dc.language.iso en en_ZA
dc.publisher MedPharm Publications en_ZA
dc.rights © 2016 The Author(s). Open Access article distributed under the terms of the Creative Commons License [CC BY-NC-ND 4.0]. en_ZA
dc.subject Cognitive enhancement en_ZA
dc.subject High workload en_ZA
dc.subject Narcolepsy en_ZA
dc.subject Stress en_ZA
dc.subject Attention deficit/hyperactivity disorder (ADHD) en_ZA
dc.subject ADHD (Attention deficit/hyperactivity disorder) en_ZA
dc.title Cognitive enhancement : a brief overview en_ZA
dc.type Article en_ZA


Files in this item

This item appears in the following Collection(s)

Show simple item record